欢迎使用我们的服务！
限时优惠，立即购买享受折扣
24小时客服在线，随时为您服务
优质产品，值得信赖

印度仿制药专卖店
登录
顶 置

文章列表

IMUNON Reports Preliminary Phase II MRD Data As Phase III Ovarian Cancer Trial Advances

2026-07-23
The Next Era Of Oncology Biosimilars

2026-07-23
Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili™, a Biosimilar to Eylea® (Aflibercept)

2026-07-23
PolyPeptide Buy To Give Samsung Biologics Capacity In Surging Peptides Sector

2026-07-23
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

2026-07-22
ViiV Healthcare to unveil new HIV treatment data at AIDS 2026

2026-07-22
NewAmsterdam And LIB Await Crucial EMA Opinions On LDL-Lowering Therapies

2026-07-22
Aurobindo Receives FDA Approval for Etodolac Tablets USP, 400 mg and 500 mg

2026-07-22
Novo Nordisk Sues Lilly Over GLP-1 Ads, Citing Inadequate Disclaimers On Dose Comparisons

2026-07-22
Aurobindo Receives FDA Approval for Etodolac Tablets USP, 400 mg and 500 mg

2026-07-21
Only Two Generic Drug Makers At Administration’s Essential Medicine Production Meeting

2026-07-21
DHPC – Paxlovid® (Nirmatrelvir/Ritonavir)

2026-07-21